· rebuilt nightly from public records
Signal Sheet
Baltimore, Maryland is home to NextCure, a publicly listed pharmaceutical preparations company. It raised $21.5M in Nov 2025 and its filings name 12 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Michael Richman | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Steven P. Cobourn | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Udayan Guha | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Timothy Mayer | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Sourav Kundu | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Kevin Shaw | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | David Kabakoff | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Elaine V. Jones | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | John G. Houston | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Stephen Webster | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Ellen G. Feigal | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Anne Borgman | SEC filing, Nov 2025 | Technology and tooling decisions |
Officer or director change
New leadershipSigned a material agreement
Corporate eventEquity raise reported to the SEC, Nov 2025. Money arrives before the spending plan does.
CapitalThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 26, 2026 | Officer or director change | New leadership | SEC filing |
| Sep 3, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Nov 12, 2025 | Raised $21.5M in equity from 12 investors | Capital | SEC filing |
Lakewave finds the right people at NextCure, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on NextCure with a free trial →| Headquarters | Baltimore, Maryland, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Ownership | Listed company |
| Raise history | $21.5M (Nov 2025) |
| Lakewave Rising | 15 · 2 kinds of evidence · rank in Maryland after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. NextCure reported a $21.5M equity raise to the SEC on Nov 12, 2025 with 12 investors.
The company's SEC filing, Nov 2025 names Michael Richman (Executive Officer) among its officers.
Baltimore, Maryland, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.